Effect of Fibrosis Regionality on Atrial Fibrillation Recurrence: Insights from DECAAF II

Overview

Journal Europace

Publisher Oxford University Press

Specialties Cardiology & Vascular Diseases
Physiology

Date 2023 Jul 10

PMID 37428891

Authors

Ala Assaf

Mario Mekhael

Charbel Noujaim

Nour Chouman

Hadi Younes

Han Feng

Abdelhadi ElHajjar

Botao Shan

Peter Kistler

Omar Kreidieh

Nassir Marrouche

Eoin Donnellan

Affiliations

Soon will be listed here.

Abstract

Aims: The amount of fibrosis in the left atrium (LA) predicts atrial fibrillation (AF) recurrence after catheter ablation (CA). We aim to identify whether regional variations in LA fibrosis affect AF recurrence.

Methods And Results: This post hoc analysis of the DECAAF II trial includes 734 patients with persistent AF undergoing first-time CA who underwent late gadolinium enhancement magnetic resonance imaging (LGE-MRI) within 1 month prior to ablation and were randomized to MRI-guided fibrosis ablation in addition to standard pulmonary vein isolation (PVI) or standard PVI only. The LA wall was divided into seven regions: anterior, posterior, septal, lateral, right pulmonary vein (PV) antrum, left PV antrum, and left atrial appendage (LAA) ostium. Regional fibrosis percentage was defined as a region's fibrosis prior to ablation divided by total LA fibrosis. Regional surface area percentage was defined as an area's surface area divided by the total LA wall surface area before ablation. Patients were followed up for a year with single-lead electrocardiogram (ECG) devices. The left PV had the highest regional fibrosis percentage (29.30 ± 14.04%), followed by the lateral wall (23.23 ± 13.56%), and the posterior wall (19.80 ± 10.85%). The regional fibrosis percentage of the LAA was a significant predictor of AF recurrence post-ablation (odds ratio = 1.017, P = 0.021), and this finding was only preserved in patients receiving MRI-guided fibrosis ablation. Regional surface area percentages did not significantly affect the primary outcome.

Conclusion: We have confirmed that atrial cardiomyopathy and remodelling are not a homogenous process, with variations in different regions of the LA. Atrial fibrosis does not uniformly affect the LA, and the left PV antral region has more fibrosis than the rest of the wall. Furthermore, we identified regional fibrosis of the LAA as a significant predictor of AF recurrence post-ablation in patients receiving MRI-guided fibrosis ablation in addition to standard PVI.

Citing Articles

Evolution in electrophysiology 100 years after Einthoven: translational and computational innovations in rhythm control of atrial fibrillation.

Schuijt E, Scherr D, Plank G, Schotten U, Heijman J Europace. 2024; 27(1).

PMID: 39729032 PMC: 11707389. DOI: 10.1093/europace/euae304.

Atrial fibrillation substrate and impaired left atrial function: a cardiac MRI study.

Chahine Y, Chamoun N, Kassar A, Bockus L, Macheret F, Akoum N Europace. 2024; 26(11).

PMID: 39523754 PMC: 11551228. DOI: 10.1093/europace/euae258.

Factors predicting the recurrence of atrial fibrillation after catheter ablation: A review.

Mo D, Wang M, Zhang P, Dai H, Guan J Heliyon. 2024; 10(13):e34205.

PMID: 39071658 PMC: 11277434. DOI: 10.1016/j.heliyon.2024.e34205.

Pre- and post-procedural cardiac imaging (computed tomography and magnetic resonance imaging) in electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and European Association of Cardiovascular Imaging of the....

Deneke T, Kutyifa V, Hindricks G, Sommer P, Zeppenfeld K, Carbucicchio C Europace. 2024; 26(5.

PMID: 38743765 PMC: 11104536. DOI: 10.1093/europace/euae108.

Assessing left atrial intramyocardial fat infiltration from computerized tomography angiography in patients with atrial fibrillation.

Saglietto A, Falasconi G, Soto-Iglesias D, Francia P, Penela D, Alderete J Europace. 2023; 25(12).

PMID: 38011712 PMC: 10751854. DOI: 10.1093/europace/euad351.

References

Istratoaie S, Vesa S, Cismaru G, Pop D, Rosu R, Puiu M . Value of Left Atrial Appendage Function Measured by Transesophageal Echocardiography for Prediction of Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation. Diagnostics (Basel). 2021; 11(8). PMC: 8394000. DOI: 10.3390/diagnostics11081465. View

Hopman L, Frenaij I, Solis-Lemus J, El Mathari S, Niederer S, Allaart C . Quantification of left atrial appendage fibrosis by cardiac magnetic resonance: an accurate surrogate for left atrial fibrosis in atrial fibrillation patients?. Europace. 2023; 25(5). PMC: 10228533. DOI: 10.1093/europace/euad084. View

Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R . Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008; 118(24):2498-505. DOI: 10.1161/CIRCULATIONAHA.108.772582. View

Sherif H . The developing pulmonary veins and left atrium: implications for ablation strategy for atrial fibrillation. Eur J Cardiothorac Surg. 2013; 44(5):792-9. DOI: 10.1093/ejcts/ezt098. View

Caixal G, Alarcon F, Althoff T, Nunez-Garcia M, Benito E, Borras R . Accuracy of left atrial fibrosis detection with cardiac magnetic resonance: correlation of late gadolinium enhancement with endocardial voltage and conduction velocity. Europace. 2020; 23(3):380-388. DOI: 10.1093/europace/euaa313. View

Gal P, Marrouche N . Magnetic resonance imaging of atrial fibrosis: redefining atrial fibrillation to a syndrome. Eur Heart J. 2015; 38(1):14-19. DOI: 10.1093/eurheartj/ehv514. View

Chieng D, Sugumar H, Ling L, Segan L, Azzopardi S, Prabhu S . Catheter ablation for persistent atrial fibrillation: A multicenter randomized trial of pulmonary vein isolation (PVI) versus PVI with posterior left atrial wall isolation (PWI) - The CAPLA study. Am Heart J. 2021; 243:210-220. DOI: 10.1016/j.ahj.2021.09.015. View

Teh A, Kistler P, Lee G, Medi C, Heck P, Spence S . Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease. J Cardiovasc Electrophysiol. 2011; 23(3):232-8. DOI: 10.1111/j.1540-8167.2011.02178.x. View

Wang A, Jiang J, Xie Z, Zhong G . Efficacy and Safety of Catheter Ablation Combined with Left Atrial Appendage Closure in the Treatment of Atrial Fibrillation: A Systematic Review and Meta-Analysis. Anatol J Cardiol. 2022; 26(3):154-162. PMC: 9372482. DOI: 10.5152/AnatolJCardiol.2021.766. View

10.

Marrouche N, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F . Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014; 311(5):498-506. DOI: 10.1001/jama.2014.3. View

11.

Takahashi Y, Sanders P, Rotter M, Haissaguerre M . Disconnection of the left atrial appendage for elimination of foci maintaining atrial fibrillation. J Cardiovasc Electrophysiol. 2005; 16(8):917-9. DOI: 10.1046/j.1540-8167.2005.40804.x. View

12.

Kanitsoraphan C, Rattanawong P, Techorueangwiwat C, Kewcharoen J, Mekritthikrai R, Prasitlumkum N . The efficacy of posterior wall isolation in atrial fibrillation ablation: A systematic review and meta-analysis of randomized controlled trials. J Arrhythm. 2022; 38(3):275-286. PMC: 9237313. DOI: 10.1002/joa3.12698. View

13.

Kistler P, Chieng D, Sugumar H, Ling L, Segan L, Azzopardi S . Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial. JAMA. 2023; 329(2):127-135. PMC: 9856612. DOI: 10.1001/jama.2022.23722. View

14.

Lee J, Shim J, Park J, Yu H, Kim T, Park J . The Electrical Isolation of the Left Atrial Posterior Wall in Catheter Ablation of Persistent Atrial Fibrillation. JACC Clin Electrophysiol. 2019; 5(11):1253-1261. DOI: 10.1016/j.jacep.2019.08.021. View

15.

Chang S, Tai C, Lin Y, Wongcharoen W, Lo L, Tuan T . Biatrial substrate properties in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2007; 18(11):1134-9. DOI: 10.1111/j.1540-8167.2007.00941.x. View

16.

AlTurki A, Huynh T, Dawas A, Alturki H, Joza J, Healey J . Left atrial appendage isolation in atrial fibrillation catheter ablation: A meta-analysis. J Arrhythm. 2018; 34(5):478-484. PMC: 6174377. DOI: 10.1002/joa3.12095. View

17.

Higuchi K, Cates J, Gardner G, Morris A, Burgon N, Akoum N . The Spatial Distribution of Late Gadolinium Enhancement of Left Atrial Magnetic Resonance Imaging in Patients With Atrial Fibrillation. JACC Clin Electrophysiol. 2018; 4(1):49-58. DOI: 10.1016/j.jacep.2017.07.016. View

18.

Assaf A, Mekhael M, Noujaim C, Chouman N, Younes H, Feng H . Effect of fibrosis regionality on atrial fibrillation recurrence: insights from DECAAF II. Europace. 2023; 25(9). PMC: 10519620. DOI: 10.1093/europace/euad199. View

19.

Cochet H, Mouries A, Nivet H, Sacher F, Derval N, Denis A . Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population. J Cardiovasc Electrophysiol. 2015; 26(5):484-92. DOI: 10.1111/jce.12651. View

20.

Marrouche N, Wazni O, McGann C, Greene T, Dean J, Dagher L . Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial. JAMA. 2022; 327(23):2296-2305. PMC: 9214588. DOI: 10.1001/jama.2022.8831. View